We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Quick Recognition of Aortic Dissection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05699395
Recruitment Status : Recruiting
First Posted : January 26, 2023
Last Update Posted : January 26, 2023
Sponsor:
Information provided by (Responsible Party):
Shanghai Zhongshan Hospital

Brief Summary:
This is an observational study that establishes a cohort of patients with high risk chest pain who have been identified by CTA for aortic dissection. We then used this cohort to validate the accuracy of identifying aortic dissection based on extremity oximetry and Doppler waveforms.

Condition or disease Intervention/treatment
Aortic Dissection Diagnostic Test: Non interventional

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Aortic Dissection Based on Pulse Oxygen and Ultrasound Doppler Waveforms
Actual Study Start Date : December 1, 2022
Estimated Primary Completion Date : December 31, 2024
Estimated Study Completion Date : May 31, 2025

Group/Cohort Intervention/treatment
Aortic Dissection Diagnostic Test: Non interventional
No intervention

Non Aortic Dissection Diagnostic Test: Non interventional
No intervention




Primary Outcome Measures :
  1. Diagnosis of aortic dissection [ Time Frame: First 24-hours during emergency dapartment stay ]
    aortic dissection confirmed by CTA



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
High risk chest pain patients
Criteria

Inclusion Criteria:

  • High risk chest pain with CTA

Exclusion Criteria:

  • shock
  • coma
  • severe peripheral vascular diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05699395


Locations
Layout table for location information
China
Zhongshan Hospital, Fudan University Recruiting
Shanghai, China
Contact: Jingchao Luo, MD    13121021484    sucapter@163.com   
Sponsors and Collaborators
Shanghai Zhongshan Hospital
Layout table for additonal information
Responsible Party: Shanghai Zhongshan Hospital
ClinicalTrials.gov Identifier: NCT05699395    
Other Study ID Numbers: QRAD2022
First Posted: January 26, 2023    Key Record Dates
Last Update Posted: January 26, 2023
Last Verified: November 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Aneurysm, Dissecting
Aneurysm
Vascular Diseases
Cardiovascular Diseases